SARTORIUS AG-VORZUG (SRT3.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SRT3 - DE0007165631
245.5 EUR
+1.75 (+0.72%)
Taking everything into account, SRT3 scores 3 out of 10 in our fundamental rating. SRT3 was compared to 19 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of SRT3 have multiple concerns. SRT3 is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SRT3 was profitable.
In the past year SRT3 had a positive cash flow from operations.
Each year in the past 5 years SRT3 has been profitable.
SRT3 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of SRT3 (1.39%) is worse than 76.19% of its industry peers.
SRT3's Return On Equity of 5.01% is on the low side compared to the rest of the industry. SRT3 is outperformed by 66.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.71%, SRT3 is doing worse than 71.43% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SRT3 is in line with the industry average of 9.26%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROIC | 4.71% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
SRT3's Profit Margin of 3.80% is on the low side compared to the rest of the industry. SRT3 is outperformed by 76.19% of its industry peers.
In the last couple of years the Profit Margin of SRT3 has declined.
SRT3 has a worse Operating Margin (14.06%) than 61.90% of its industry peers.
In the last couple of years the Operating Margin of SRT3 has declined.
With a decent Gross Margin value of 46.48%, SRT3 is doing good in the industry, outperforming 66.67% of the companies in the same industry.
SRT3's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
SRT3 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
SRT3 has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SRT3 has been increased compared to 5 years ago.
Compared to 1 year ago, SRT3 has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.45 indicates that SRT3 is not a great score, but indicates only limited risk for bankruptcy at the moment.
SRT3 has a Altman-Z score of 2.45. This is in the lower half of the industry: SRT3 underperforms 61.90% of its industry peers.
SRT3 has a debt to FCF ratio of 8.92. This is a slightly negative value and a sign of low solvency as SRT3 would need 8.92 years to pay back of all of its debts.
The Debt to FCF ratio of SRT3 (8.92) is worse than 61.90% of its industry peers.
A Debt/Equity ratio of 1.28 is on the high side and indicates that SRT3 has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.28, SRT3 is doing worse than 76.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Altman-Z | 2.45 |
ROIC/WACC0.56
WACC8.36%
2.3 Liquidity
A Current Ratio of 0.95 indicates that SRT3 may have some problems paying its short term obligations.
With a Current ratio value of 0.95, SRT3 is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
SRT3 has a Quick Ratio of 0.95. This is a bad value and indicates that SRT3 is not financially healthy enough and could expect problems in meeting its short term obligations.
SRT3 has a Quick ratio of 0.49. This is amonst the worse of the industry: SRT3 underperforms 90.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
SRT3 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.34%, which is quite impressive.
The earnings per share for SRT3 have been decreasing by -11.87% on average. This is quite bad
The Revenue has been growing slightly by 5.82% in the past year.
Measured over the past years, SRT3 shows a quite strong growth in Revenue. The Revenue has been growing by 13.10% on average per year.
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
3.2 Future
The Earnings Per Share is expected to grow by 19.29% on average over the next years. This is quite good.
SRT3 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.99% yearly.
EPS Next Y22.67%
EPS Next 2Y21.45%
EPS Next 3Y22.86%
EPS Next 5Y19.29%
Revenue Next Year5.32%
Revenue Next 2Y6.73%
Revenue Next 3Y8.71%
Revenue Next 5Y8.99%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
SRT3 is valuated quite expensively with a Price/Earnings ratio of 53.84.
SRT3's Price/Earnings ratio is rather expensive when compared to the industry. SRT3 is more expensive than 80.95% of the companies in the same industry.
When comparing the Price/Earnings ratio of SRT3 to the average of the S&P500 Index (26.92), we can say SRT3 is valued expensively.
A Price/Forward Earnings ratio of 40.62 indicates a quite expensive valuation of SRT3.
Based on the Price/Forward Earnings ratio, SRT3 is valued a bit more expensive than 76.19% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.46, SRT3 is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.84 | ||
| Fwd PE | 40.62 |
4.2 Price Multiples
SRT3's Enterprise Value to EBITDA is on the same level as the industry average.
SRT3's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 38.41 | ||
| EV/EBITDA | 24.03 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SRT3's earnings are expected to grow with 22.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.37
PEG (5Y)N/A
EPS Next 2Y21.45%
EPS Next 3Y22.86%
5. Dividend
5.1 Amount
SRT3 has a yearly dividend return of 0.39%, which is pretty low.
Compared to an average industry Dividend Yield of 0.60, SRT3 pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.00, SRT3's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
5.2 History
The dividend of SRT3 has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
37.92% of the earnings are spent on dividend by SRT3. This is a low number and sustainable payout ratio.
SRT3's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP37.92%
EPS Next 2Y21.45%
EPS Next 3Y22.86%
FRA:SRT3 (12/23/2025, 5:36:15 PM)
245.5
+1.75 (+0.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.38B
Revenue(TTM)3.52B
Net Income(TTM)133.70M
Analysts80
Price Target347.23 (41.44%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP37.92%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.85%
Min EPS beat(2)-10.52%
Max EPS beat(2)4.83%
EPS beat(4)1
Avg EPS beat(4)-3.47%
Min EPS beat(4)-10.52%
Max EPS beat(4)4.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)1.91%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.46%
PT rev (3m)11.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.45%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)-0.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.71%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.84 | ||
| Fwd PE | 40.62 | ||
| P/S | 5.23 | ||
| P/FCF | 38.41 | ||
| P/OCF | 21.03 | ||
| P/B | 6.89 | ||
| P/tB | N/A | ||
| EV/EBITDA | 24.03 |
EPS(TTM)4.56
EY1.86%
EPS(NY)6.04
Fwd EY2.46%
FCF(TTM)6.39
FCFY2.6%
OCF(TTM)11.68
OCFY4.76%
SpS46.97
BVpS35.63
TBVpS-35.24
PEG (NY)2.37
PEG (5Y)N/A
Graham Number60.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROCE | 6.33% | ||
| ROIC | 4.71% | ||
| ROICexc | 4.98% | ||
| ROICexgc | 17.77% | ||
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% | ||
| FCFM | 13.61% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexgc growth 3Y-35.26%
ROICexgc growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Debt/EBITDA | 3.69 | ||
| Cap/Depr | 92.32% | ||
| Cap/Sales | 11.25% | ||
| Interest Coverage | 2.65 | ||
| Cash Conversion | 94.72% | ||
| Profit Quality | 357.97% | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 | ||
| Altman-Z | 2.45 |
F-Score7
WACC8.36%
ROIC/WACC0.56
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
EPS Next Y22.67%
EPS Next 2Y21.45%
EPS Next 3Y22.86%
EPS Next 5Y19.29%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
Revenue Next Year5.32%
Revenue Next 2Y6.73%
Revenue Next 3Y8.71%
Revenue Next 5Y8.99%
EBIT growth 1Y18.65%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year101.42%
EBIT Next 3Y38.38%
EBIT Next 5Y26.81%
FCF growth 1Y123.33%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y6.61%
OCF growth 3Y4.07%
OCF growth 5Y20.79%
SARTORIUS AG-VORZUG / SRT3.DE FAQ
What is the ChartMill fundamental rating of SARTORIUS AG-VORZUG (SRT3.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE.
What is the valuation status for SRT3 stock?
ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS AG-VORZUG (SRT3.DE). This can be considered as Overvalued.
Can you provide the profitability details for SARTORIUS AG-VORZUG?
SARTORIUS AG-VORZUG (SRT3.DE) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for SRT3 stock?
The Price/Earnings (PE) ratio for SARTORIUS AG-VORZUG (SRT3.DE) is 53.84 and the Price/Book (PB) ratio is 6.89.
What is the expected EPS growth for SARTORIUS AG-VORZUG (SRT3.DE) stock?
The Earnings per Share (EPS) of SARTORIUS AG-VORZUG (SRT3.DE) is expected to grow by 22.67% in the next year.